Methods and systems to determine multi-parameter managed alarm hierarchy during patient monitoring

Information

  • Patent Grant
  • 11562825
  • Patent Number
    11,562,825
  • Date Filed
    Wednesday, May 20, 2020
    4 years ago
  • Date Issued
    Tuesday, January 24, 2023
    a year ago
Abstract
The present specification discloses systems and methods of patient monitoring in which multiple sensors are used to detect physiological parameters and the data from those sensors are correlated to determine if an alarm should, or should not, be issued, thereby resulting in more precise alarms and fewer false alarms. Electrocardiogram readings can be combined with invasive blood pressure, non-invasive blood pressure, and/or pulse oximetry measurements to provide a more accurate picture of pulse activity and patient respiration. In addition, the monitoring system can also use an accelerometer or heart valve auscultation to further improve accuracy.
Description
FIELD OF THE INVENTION

The present specification invention relates to patient monitoring systems. In particular, the specification discloses systems and methods for analyzing a plurality of physiological parameters to promote, demote, or suppress alarm conditions.


BACKGROUND OF THE INVENTION

Most patient monitoring is typically implemented by measuring and observing a plurality of physiological parameters such as: ECG (Electrocardiogram), Pulse Oximetry (involving measuring blood oxygen levels or SpO2), Respiration (derived from ECG signal or from other parameters), Invasive Blood Pressure (or IBP that involves direct measurement of blood pressure from an indwelling catheter), and Non-Invasive Blood Pressure (or NIBP that involves use of automated oscillometric methods).


Typically these physiological parameters have a set of vital signs and derived measurements which can be configured to alert a caregiver if the measured values move outside of configured ranges. Each parameter has a plurality of alarms that can be considered to be of different priorities. However, prior art methods and systems tend to treat each of these parameters independently for deciding/determining alarm situations or fail to provide a workable mechanism for effectively determining whether an alarm state, derived from the signal of a particular patient monitoring device, is false, likely to be false, or sufficiently indicative of the state of a patient to warrant alerting a caregiver. As a result, the clinical user may experience an unacceptable number of alarms within these patient monitoring systems. The caregiver will ultimately see a conglomeration of alarm states from various fluctuations for each of the parameters, leading to unnecessary distraction and caregiver apathy regarding alarms.


Accordingly there is need in the art for methods and systems that effectively suppress or demote the number of false alarms the user sees and to make sure that when the system alarms there is a significant probability that the patient requires immediate attention.


SUMMARY OF THE INVENTION

In one embodiment, the present specification discloses a computer readable medium storing a plurality of programmatic instructions for processing data indicative of physiological parameters comprising: a) code for receiving ECG data generated at least in part by an ECG device, wherein said ECG data comprises a plurality of features and wherein at least one of said features has a designation associated therewith and a time of occurrence associated therewith; b) code for receiving pulse data indicative of a patient's pulse response, wherein said pulse data is obtained from at least one sensor separate from said ECG device and wherein said pulse data has a designation associated therewith and a time of occurrence associated therewith; c) code for correlating the designation and time of said at least one feature of the ECG data with the designation and time of the pulse data to determine a degree of correlation; and d) code for causing an alarm to issue, wherein the alarm is only issued if said degree of correlation indicates the patient has an abnormal heart condition.


Optionally, the plurality of programmatic instructions further comprises code for comparing said degree of correlation to a predetermined value. The code for causing an alarm to issue only causes the alarm to issue if said comparison indicates the patient has an abnormal heart condition. The designation of at least one feature of the ECG data is either normal or abnormal. The designation of the pulse data is either normal or abnormal. The correlation functions to determine if an abnormal feature in the ECG data is correlated in time with an abnormal pulse. If the correlation determines an abnormal feature in the ECG data is correlated in time with an abnormal pulse, an alarm indicative of an abnormal heart condition is issued. If not, an alarm is not issued or, if generated by another source, is actively suppressed. The correlation is further dependent upon at least one of an amplitude of an ECG signal, amplitude of a pulse signal, duration of a pulse signal, noise level within said ECG data, or noise level within said pulse data. The at least one sensor is an invasive blood pressure (IBP) monitoring device, a non-invasive blood pressure (NIBP) monitoring device, heart valve sounds monitoring device, or pulse oximetry (SpO2) monitoring device. The plurality of instructions further comprises code for causing at least one sensor to initiate a collection of pulse data based on said ECG data. The code causes a non-invasive blood pressure monitoring device to inflate a cuff and collect pulse data when said ECG data is representative of a heart rhythm indicative of atrial fibrillation. The plurality of instructions further comprises code to cause a non-invasive blood pressure monitoring device to inflate a cuff and collect pulse data based upon said correlation.


In another embodiment, a computer readable medium storing a plurality of programmatic instructions for processing data indicative of physiological parameters comprising: a) code for receiving bio-impedance data generated at least in part by a respiration monitoring device, wherein said bio-impedance data comprises a plurality of features and wherein at least one of said features has a designation associated therewith and a time of occurrence associated therewith; b) code for receiving respiration data indicative of a patient's respiration, wherein said respiration data is obtained from at least one sensor separate from said respiration monitoring device and wherein said respiration data has a designation associated therewith and a time of occurrence associated therewith; c) code for correlating the designation and time of said at least one feature of the ECG data with the designation and time of the respiration data to determine a degree of correlation; and d) code for causing an alarm to issue, wherein the alarm is only issued if said degree of correlation indicates the patient has abnormal respiration.


Optionally, the respiration monitoring device is at least one of a capnography device, pneumatic respiration transducer device, strain gauge or stretch gauge. The sensor is at least one of an ECG device, invasive blood pressure (IBP) monitoring device, pulse oximetry (SpO2) monitoring device, or motion detecting device. The motion detecting device is an accelerometer. The motion detecting device is an accelerometer integrated with an ECG electrode. The designation of at least one feature of the bio-impedance data is either normal or abnormal. The designation of the respiration data is either normal or abnormal. The correlation functions to determine if an abnormal feature in the bio-impedance data is correlated in time with abnormal respiration data. If said correlation determines an abnormal feature in the bio-impedance data is correlated in time with abnormal respiration data, an alarm indicative of an respiration condition is issued. The respiration condition is a sleep apnea event. The plurality of instructions further comprises code to receive motion data from said accelerometer and determine whether a patient has fallen. The plurality of instructions further comprises code to receive motion data from said accelerometer, to determine whether a patient is engaged in an activity which would increase the patient's respiration rate, and to cause said alarm to issue or not issue based, at least in part, on said determination. The plurality of instructions further comprises code to receive motion data from said accelerometer, to receive ECG data, to determine whether variations in ST segments of said ECG data are caused by patient activity, and to cause said alarm to issue or not issue based, at least in part, on said determination.


It should be appreciated that the plurality of instructions described herein are stored in a memory structure, such as a hard disk, ROM, RAM, or any other type of memory device, and executed by at least one processor. The instructions may be co-located with the sensors or monitors or may be remote therefrom. They may be integrated into a separate controller or computer that is in data communication with the sensors, or operated as a software module integrated into one or more of the sensing devices themselves.





BRIEF DESCRIPTION OF THE DRAWINGS

These and other features and advantages of the present invention will be appreciated, as they become better understood by reference to the following detailed description when considered in connection with the accompanying drawings, wherein:



FIG. 1 shows a flow diagram depicting a method of using a plurality of parameters to determine an alarm hierarchy;



FIG. 2a is a graphical representation of an ECG (III) signal with waveform noise and a corresponding IBP (ART) signal showing normal cardiac activity for the same interval;



FIG. 2b is a graphical representation of an ECG (III) signal with waveform noise and a corresponding IBP (ART) signal showing lack of cardiac activity for the same interval;



FIG. 3a is a graphical representation showing plethysmograph-assisted analysis for atrial ectopic beats;



FIG. 3b is a graphical representation of ECG (V1), ECG2 (II) and SpO2 signals at time T0 for plethysmograph-assisted ventricular beat analysis;



FIG. 3c is a graphical representation of ECG (V1), ECG2 (II) and SpO2 signals at time T1 for plethysmograph-assisted ECG signal noise analysis;



FIG. 4 is a graphical representation of invasive pressure systolic peak modulation with respiration signals;



FIG. 5a is an illustration of one embodiment of a disposable ECG electrode;



FIG. 5b is an illustration of the disposable ECG electrode shown in FIG. 4a, further showing a reusable snap electrode wire;



FIG. 5c is an illustration of the reusable snap electrode wire shown in FIG. 4b, attached to the ECG electrode and with an integrated accelerometer;



FIG. 6 is a graphical representation of chest wall movement in a patient wearing an accelerometer while supine;



FIG. 7 is a graphical representation of chest wall movement in the same patient wearing an accelerometer after standing up; and



FIG. 8 is a graphical representation of chest wall movement in the same patient wearing an accelerometer while walking.





DETAILED DESCRIPTION

In one embodiment, the present specification discloses a system and method for collectively analyzing a plurality of physiological parameters and using the results to promote, demote, or suppress alarm notification. The present specification provides the benefits of producing more specific patient alarms and reducing the occurrence of false alarms, thereby permitting the monitoring personnel to perform more effectively.


In one embodiment, ECG parameters are considered with any one, or a combination of, the following sensor measurements: Invasive Blood Pressure (IBP); Non-Invasive Blood Pressure (NIBP); and, Blood Oxygen Level (SpO2), such as via pulse oximetry. For each parameter there is a corresponding waveform signal that is created by measuring and sampling the signal off of a transducer.


For ECG, a waveform is derived from an electrical signal detected by cutaneously placed electrodes which respond to the propagation of electrical signals in heart muscles. In one embodiment, IBP uses an indwelling catheter with a transducer to create a voltage proportional to the pressure which results from the mechanical pumping action of the heart.


NIBP measurements are obtained via an external cuff coupled with an electronic pressure transducer. The cuff is automatically inflated and deflated at regular intervals to measure pressure oscillations. While NIBP is used to measure blood pressure, typically the pulse rate is also determined and reported as part of that process. For example, a caregiver may establish or set up a monitor to take an NIBP measurement every 15 minutes. This is typical in an operating room (OR) or in the post-anesthesia care unit (PACU) settings. Once every 15 minutes an NIBP measurement might report a value such as “120/80 (92) HR 77” (i.e. systolic pressure=120 mmHg, diastolic pressure=80 mmHg, mean arterial pressure=92 mmHg, and pulse rate=77 bpm). In this scenario, the NIBP parameter essentially provides an independent measure of pulse rate but only does so every 15 minutes.


In another embodiment, for purposes of the present specification, the cuff is inflated periodically, such as once every few minutes to a pressure adequate to measure the pulse rate. In one embodiment, the cuff is inflated to a diastolic pressure equal to or slightly greater than the most recently measured diastolic pressure. In another embodiment, the cuff is inflated to a mean arterial pressure equal to or slightly greater than the most recently measured mean arterial pressure. In another embodiment, the cuff is inflated so that both the diastolic pressure and mean arterial pressure are equal to or slightly greater than the most recently measured corresponding pressure. Pulses detected while the cuff is inflated are used as an alternate source of pulse information in the same way as described for IBP and SpO2.


In yet another embodiment, NIBP is used to measure the strength and regularity of the pulse signal in addition to the pulse rate.


SpO2 waveforms are derived by measuring variations in the amount of light detected by a photo-receptor after the light is shined through a patient's skin. The anatomical site used must have arterial blood flowing through it in sufficient quantity, such as, a fingertip or ear.


In any case, for each parameter, a signal is created which corresponds to either the electrical activity at the heart or the pumping action of the heart and its subsequent propagation into the periphery of the body. The individual parameters provide the caregiver with independent means of verifying agreement between results obtained via the electrical signal collected at the skin (ECG) and the mechanical response measured as pulse signals via invasive pressure lines (IBP), an external cuff (NIBP), or a pulse oximeter (SpO2).


Further, when monitoring of the patient begins, each waveform is processed independently to produce a record of where each event (beat or pulse) occurs and to measure and record many parameters of each event. For each ECG event (i.e. heartbeat) the system measures and records the height and direction of the waveform deflections in multiple leads and records if the deflection pattern is typical and if it fell in the expected place in the sequence based on the previous events. In addition, other factors such as duration, rate of change, and locations of local minima and maxima within each lead are recorded. Ultimately, all recorded measurements are combined and compared to the previous beats and a diagnosis as to whether the beat is representative of “normal” or “abnormal” conduction is made.


For the purposes of the current specification, determining whether an alarm should be issued is a function of the time of occurrence of an ECG signal, (usually indexed off a prominent feature of the ECG waveform), whether the ECG signal designation is “normal” or “abnormal”, and an estimate of the system's confidence in the beat's diagnosis. If the beat was normal in all measured parameters (closely matched preceding beats), occurred at the expected time, and all other measures of signal consistency and quality are high, the system will have high confidence that this signal is reliable, e.g. a confidence in excess of a predetermined threshold. All features measured by the ECG signal processing algorithm are reported to the signal correlation software module which then processes the data to generate the confidence level and compare the confidence level to a threshold. Similarly, other waveform parameters are recorded and reported (such as, but not limited to IBP, NIBP, and SpO2), including measurements for time of occurrence, amplitude, duration, peak change rates, and signal quality to the signal correlation software module.


Measured feature data from each parameter is combined using the signal correlation software module. In normal conditions, each electrical pulse, as measured by ECG, produces a pulse response which is also measured in the other parameters. Over time a relationship between time of occurrence, signal amplitude, pulse duration, noise level and confidence is created. When the signal quality is good, and each ECG complex is capturing a good mechanical response in the heart, and each of the other parameters is generating a good pulse response, the agreement or correlation between the each parameter is very high.


In one embodiment, when an abnormal beat (early or late, atrial or ventricular ectopic) is detected via ECG, there is a strong possibility of a reduced pulse response in one of the other parameters. If this ectopic beat occurs with some frequency, then a pattern is established between the ECG detecting “abnormal” conduction and the reduced pulse response in the other parameters. This pattern is recognized by the system as exhibiting a high confidence for representing a real event, thereby triggering an alarm.


In one embodiment, when the ECG signal is affected by noise (usually a result of patient movement) and an “abnormal” conduction is reported, the other parameters report normal pulse response. In this embodiment, the conduction is actually “normal” but the ECG signal is obscured by noise. The information from the other parameters (good and consistent pulse signal at the expected time with high confidence) is used to suppress any alarm or notification about the abnormal beat. The ECG then uses the information gathered from the other parameters to reconsider its diagnosis entirely. Similarly, the feedback from the pulse sources can help demote or suppress high and low pulse rate alarms and asystole alarms that are due to signal quality issues at the ECG electrodes. This is a result of having established a previous high correlation between the ECG and pulse sources. When the data from the pulse sources is of good quality and produces the expected results the system can suppress or demote the alarm from the ECG source.


Conversely, when an actual event occurs, such as an asystolic pause (the heart stops beating), the ECG will detect and report no activity and the pulse sources will detect and report no pulse responses. All these parameters together are producing signals which are closely correlated and suggest the heart has stopped. The system will then trigger an alarm with the highest urgency.


The present invention is directed towards multiple embodiments. The following disclosure is provided in order to enable a person having ordinary skill in the art to practice the invention. Language used in this specification should not be interpreted as a general disavowal of any one specific embodiment or used to limit the claims beyond the meaning of the terms used therein. The general principles defined herein may be applied to other embodiments and applications without departing from the spirit and scope of the invention. Also, the terminology and phraseology used is for the purpose of describing exemplary embodiments and should not be considered limiting. Thus, the present invention is to be accorded the widest scope encompassing numerous alternatives, modifications and equivalents consistent with the principles and features disclosed. For purpose of clarity, details relating to technical material that is known in the technical fields related to the invention have not been described in detail so as not to unnecessarily obscure the present invention.



FIG. 1 shows a flow diagram depicting a method of analyzing a plurality of parameters to establish alarm hierarchy, in terms of the alarm's significance, thereby determining if an alarm is to be presented (via audio or visible signal) to a caregiver. In one embodiment of the multi-parameter alarm hierarchy method of the present invention, ECG parameters are considered in conjunction with IBP (Invasive Blood Pressure), NIBP (Non-Invasive Blood Pressure), and/or SpO2 (Blood oxygen level, such as via pulse oximetry techniques) sensor measurements. To begin with, parameters such as the time of occurrence, signal strength, amplitude and regularity of every pulse signal, recorded by an IBP, NIBP, and/or SpO2 sensor, are measured/recorded 105. Thereafter, at step 110 a one-to-one correlation is developed between each measured ECG complex and the resultant pulse signal as measured on IBP, NIBP, and/or SpO2.


In step 115, the correlation between the pulse sources (that is, IBP, NIBP, and SpO2 sensors) and the ECG signal is continuously monitored and analyzed. Heart rate alarm condition is determined, in step 120, after giving due consideration to the composite pulse rate readings from the IBP, NIBP, and/or SpO2 sensors and the ECG to improve the overall level of confidence for an alarm situation. If the overall level of confidence is high, such as when parameters from multiple sources are in tandem, in step 125 an alarm is sounded or promoted. However, if the level of confidence is low, such as when parameters from relevant multiple sources are not in agreement with each other, then in step 130, the alarm is suppressed or demoted.


In one embodiment, for example, false ECG arrhythmia alarms are detected and suppressed, using the aforementioned method of the present invention, by simultaneously observing pulse signals from invasive pressure sensor, cuff pressure sensor, and/or the pulse oximeter and when adequate confidence in the pulse signal(s) allows the suppression of the ECG based alarm. Thus, if a sufficiently strong rhythmic pulse signal as measured on IBP, NIBP, and SpO2 sensors is present, then there exists a reasonable certainty that the patient is not experiencing arrhythmia. In such example, an ECG alarm will be demoted or suppressed in the hierarchy of alarms to be sounded to a caregiver, in accordance with the method of the present invention, thereby avoiding false alarms related to arrhythmia conditions such as asystole, ventricular tachycardia, ventricular couplets and ventricular runs. Similarly, an ECG arrhythmia alarm is promoted if the condition is confirmed or corroborated by information form the pulse signal sources of IBP, NIBP, and/or SpO2. For example, an ectopic beat will often create less pulse pressure and blood flow. This decreased peripheral pressure or flow can be detected on the SpO2 signal, external cuff, and/or an arterial pressure line. The presence of the reduced signal in the Spot, cuff, and/or pressure lines confirms or increases the confidence to label those beats as ectopic beats.



FIG. 2a is a graphical representation of an ECG (III) signal 200 with waveform noise 205 and a corresponding IBP (ART) signal 201 showing normal cardiac activity 210 for the same interval. This figure shows an ECG waveform 200 with noise 205 closely resembling ventricular tachycardia, which would normally generate a high priority alarm. However, because the simultaneous IBP waveform 201 clearly shows continuing pulse with very regular rhythm and amplitude 210, this high priority alarm is demoted to a low priority alarm indicating “Noisy ECG”. FIG. 2b is a graphical representation of an ECG (III) signal 202 with waveform noise 220 and a corresponding IBP (ART) signal 203 showing lack of cardiac activity 225 for the same interval. This figure shows an episode of ventricular tachycardia 220 which is confirmed by the cessation of pulsatile activity 225 in the invasive pressure waveform. Due to the great degree of correlation between the signals obtained from the two independent measurements, a high priority alarm is promoted.



FIG. 3a is a graphical representation showing plethysmograph-assisted analysis for atrial ectopic beats. As observable in the waveform of FIG. 3a, a weak SpO2 plethysmograph signal 305 confirms ectopic beats 310 in the ECG waveform.



FIG. 3b is a graphical representation of ECG (V1) 311, ECG2 (II) 312 and SpO2 313 signals at time T0 for plethysmograph-assisted ventricular beat analysis and FIG. 3c is a graphical representation of ECG (V1) 321, ECG2 (II) 322 and SpO2 323 signals at time T1 for plethysmograph-assisted ECG signal noise analysis. Now referring to FIG. 3b, the ventricular beat, V, is corroborated or confirmed in the SpO2 graph 313 that correspondingly shows little or no signal response 315. This corroboration improves the overall confidence thereby promoting a heart rate alarm condition. However, as the ECG data gets noisy at the end of the strip 320, shown in FIG. 3b, and the beginning of the strip 325, shown in FIG. 3c, the correlated SpO2 waveforms provide confirmation that none of the noise is likely a real beat. This allows for demotion or suppression of a heart rate alarm that would otherwise have been sounded if SpO2 waveform was not considered and the ECG heart rate parameter were relied upon in isolation.


In another embodiment, a NIBP (Non-Invasive Blood Pressure) cuff is used as an alternative signal source in the same way as IBP and/or SpO2, when necessary. The system will inflate the cuff periodically and also when the primary heart rate sources (ECG, IBP, SpO2) are unavailable, in disagreement, or indicate a serious condition that needs to be verified. The system will perform periodic inflations and also on-demand inflation as described below.


For example, in one embodiment, a patient is monitored on NIBP and ECG only. The patient inadvertently removes some or all of their ECG electrodes such that the ECG parameter is effectively disabled. At this point the cuff inflates and begins “backup” monitoring of the pulse with NIBP. If the NIBP is producing a reasonable “in-bounds” pulse signal the system propagates a low-priority alarm to the caregiver (“Check ECG leads” or “Signal unavailable”).


However, if the pulse rate is indicating an alarm condition (such as no pulse, high rate, low rate, or very different pulse strength or regularity than previously measured), the alarm message is elevated to a clinical alarm such as “ECG unavailable NIBP indicating pulse rate>120 bpm—Check Patient”.


In another example, if an ECG analysis suggests a rhythm change to atrial fibrillation, the NIBP cuff on the patient is inflated in order to monitor the strength and regularity of the pulse measured in the NIBP cuff. This additional NIBP data is then used to confirm or suppress the atrial fibrillation diagnosis. Similarly, out of bounds heart rate alarms are checked via the NIBP cuff to confirm or deny rate violations before the alarm is sounded.


Persons of ordinary skill in the art should note that a plurality of other combinations of parameters can be utilized in accordance with the alarm hierarchy determination method of the present invention and that the use of parameters such as ECG, IBP, NIBP, and/or SpO2 is only by way of a non-limiting example. However, it should be noted that the accurate suppression or promotion of an alarm requires the careful correlation of different physiological parameters to ensure that real events are being tracked and reported. It should also be noted herein that the occurrence of the ECG derived event is still reported as a notification or display to a patient monitor, but not as a clinical alarm, which is any visual or auditory signal designed to attract human attention and is indicative of an abnormal physiological state requiring immediate medical attention. This enables the caregiver to review excluded events from the multi-parameter analysis of the present invention.


According to another aspect of the present invention a plurality of physiological cross-parameters are also analyzed to determine alarm hierarchy. Persons of ordinary skill in the art would appreciate that a respiration signal can be derived from invasive blood pressure lines, depending on placement of a catheter, the hemodynamic condition of the patient, and the characteristics of respiration. In one embodiment, the invasive pressure line signal, observable as a pulse pressure variation which is driven by respiration, is used as a secondary respiration signal. Thus, the invasive pressure line signal is used in conjunction with a primary respiration signal source to confirm respiration rate changes or to identify apnea events.



FIG. 4 is a graphical representation of invasive pressure systolic peak modulation with respiration signals. Thus, FIG. 4 shows signal plots of how invasive pressure systolic peaks 405 modulate with respiration signals 410 in accordance with an embodiment of the present invention. This modulation is measured and used as a secondary source of respiration rate measurement. As observable in FIG. 4, the relationship between the bio-impedance respiration signal 410 and the invasive pressure signal 405 is established in the first six seconds. As the bio-impedance signal 410 degrades, at 415, the pressure signal 405 is used to establish the respiration rate even though the bio-impedance signal 410 is temporarily unavailable, thereby suppressing a false respiration rate related alarm. However, the fact that bio-impedance is unavailable is still reported as an event and not as a clinical alarm.


In one embodiment, a secondary respiration signal is derived by monitoring changes in the amplitudes of ECG signal, in multiple leads, during respiration cycle. These amplitude changes are a result of the heart moving in the chest relative to the measuring electrodes owing to movement of the chest and lungs during respiration. This, in turn, creates another pseudo-respiration signal that is used to confirm respiration changes when studied/analyzed in conjunction with a primary source of respiration signal, such as capnography, PRT (Pneumatic Respiration Transducer), a strain or a stretch gauge or any bio-impedance signal source known to persons of ordinary skill in the art. Since the pseudo-signal is not expected to be present and therefore reliable all the time (since in this embodiment the pseudo-signal depends on chest/lung movement), the pseudo-signal is used only when a high correlation is observed between the pseudo-signal and a primary respiration signal.


In another embodiment, a secondary respiration signal is derived by monitoring changes in the amplitudes of the SpO2 plethysmograph or small changes in the oxygen saturation signal during the respiration cycle. These amplitude changes are a result of the heart moving in the chest owing to movement of the chest and lungs during respiration, thus creating another pseudo-respiration signal that is used to confirm respiration changes when studied/analyzed in conjunction with a primary source of respiration signal.


In one embodiment, motion signals from a motion detecting accelerometer are used as pseudo or secondary respiration signals in conjunction with a primary source of respiration signals. In one embodiment of the present invention, an accelerometer is integrated into an electrode wire snap thereby rendering the accelerometer virtually reusable with very low disposable cost.



FIG. 5a is an illustration of one embodiment of a disposable ECG electrode while FIG. 5b is an illustration of the disposable ECG electrode shown in FIG. 5a further showing a reusable snap electrode wire.


In one embodiment of the present invention, an accelerometer (not shown) is integrated into the electrode wire snap 505. In one embodiment, as shown in FIG. 5c, the electrode wire is attached to the ECG electrode 500. In one embodiment, a tri-axial accelerometer is used, such as, but not limited to, the ADXL330 3-axis iMEMS® accelerometer from Analog Devices. Persons of ordinary skill in the art should appreciate that the accelerometer can be integrated into other devices, apart from ECG electrodes, such as a cell-phone or other devices like the iPod™ from Apple™.


In one embodiment the spatial orientation of the accelerometer is maintained such that it is consistently applied in the same orientation relative to a patient. To enable this, mechanical fixtures such as locking snaps, tabs or adhesives are used to position, align and lock the accelerometer snap consistently into a position. In one embodiment, markings, such as a note saying “this end up”, are placed on the electrode/accelerometer along with a locking tab or any other mechanical fixture to ensure that the accelerometer is always oriented the same way relative to the body and stays in this position. The accelerometer integrated ECG electrode is appropriately placed on a patient such that the position allows for maximized chest wall motion. Persons of ordinary skill in the art should appreciate that the accelerometer can be used as integrated with an ECG electrode and/or on a standalone basis. In one embodiment, two or more different 3-axis accelerometers are used and positioned in multiple locations on the patient's torso in order to maximize detection of measured quantities.


In situations where only the accelerometer signals are available while other primary respiration signals are unusable or unavailable—the accelerometer data is used as a proxy “dead-in-bed” detector which sounds an alarm when no movement or respiration signal is present. However, in situations where another source of primary respiration signal (such as bio impedance, stress or strain gauge, capnography) is available, the accelerometer signal is used to validate the primary respiration signal. Thus, when the accelerometer measurements are in agreement with other primary source(s) of measurement, there is increased confidence that the measured signal is correct and an alarm is sounded to the caregiver. However, data from the proxy accelerometer signal is used to suppress false alarms (for conditions such as low or high breath rate, apnea) from other respiration signal sources when the signal from the accelerometer indicates a different respiration signal with sufficiently high confidence. Thus, data from a plurality of sources is co-analyzed to produce a more robust measurement of respiration. This increases the quality of the respiration signal analysis and reduces unnecessary alarms for the caregiver.


According to one aspect of the present invention, motion signals from an accelerometer are used to determine and monitor patient posture. For example, the amount of time a patient spends in standing, sitting, active and/or supine positions is calculated and reported.



FIG. 6 is a graphical representation of chest wall movement in a patient wearing an accelerometer while supine. A 3-axis accelerometer measures applied force in each of 3 different orthogonal directions. FIG. 6 depicts a graphical representation of the signal created by a chest worn accelerometer for a patient while lying down. The data represents 1 minute in time and shows the signal from each axis of the accelerometer. The effects of respiration can be seen in FIG. 6, particularly in waveform G 605 and waveform Y 610 and, to a lesser extent, in waveform B 615. Waveform G's 605 mean signal is about 300 counts, waveform Y's 610 is about −150 counts, and waveform B's 615 is −350 counts.



FIG. 7 is a graphical representation of chest wall movement in the same patient wearing an accelerometer after standing up. The positional change of the patient thus results in dramatic changes in the mean levels of each signal. In comparison with a supine patient, waveform G's 705 mean level is now −130 counts, waveform Y's 710 is −650 counts, and waveform B's 715 is 150 counts. This effect is a result of the change in spatial orientation of the 3-axis accelerometer relative to the gravitational field of the earth. Provided that the accelerometer is attached to the patient in the same orientation each time, then the relative mean values of the signal off each axis will tell the clinician if the patient is “upright” (could be standing or sitting), supine, or perhaps partially propped up with pillows if between an upright and supine position.


This information is useful in assessing discharge decisions from a monitoring perspective. Similarly, sleep positions, such as on back, left side, right side, stomach, are monitored. In one embodiment, the number of position changes per hour is measured and quantified and used in conjunction with motion measurements from accelerometer to determine if a patients overall activity is what would be expected for a patient in a given state. For example, detection of lack of motion or posture change is notified to a caregiver as a need for the patient to be turned in bed to prevent bed sores.


In another embodiment, data collected by the accelerometer signifying position changes is used to detect falls and trigger alarm notification. For example, waveform signatures denoting a sudden change from a standing position to a supine position preceded by an impact would alert the system of a possible patient fall. The system would then promote or trigger an alarm notification.


According to another aspect of the present invention, apart from monitoring patient posture, accelerometer signals are also used to measure patient activity. In one embodiment, accelerometer signals are used to both count and record patient steps and patient step rates.



FIG. 8 is a graphical representation of chest wall movement in the same patient wearing an accelerometer while walking. The time axis represents 10 seconds of data collected while the patient was walking. The walking signature is quite different from the supine and standing signatures depicted in FIG. 6 and FIG. 7, respectively. The user can easily pick out each footfall (in waveform Y 810 and waveform G 805 in particular) and to see that in 10 seconds approximately 19 steps were taken. The actual steps could be measured by looking across all 3 bands for the characteristic rapid changes in each axis signal. These events can be counted (pedometer type function) and reported as a count or as a rate; for example, in this ten second time period, the event can be represented as 19 total steps or 114 steps per minute.


This information is used to calculate statistics such as the percentage of time the patient spends walking and at what step rates. Such statistics when analyzed in the long term over hours and days, in one embodiment, help in assessing ambulatory patients for parameters such as how much they are moving, how does their activity level compare to similar patients, whether or not they are candidates for discharge, and/or any other parameters as would be advantageously evident to persons of ordinary skill in the art.


According to another aspect of the present invention, the accelerometer signals are used to detect motion/activity artifacts induced signal changes in other physiological parameters being monitored for the patient. In one embodiment this is useful in suppressing or demoting an alarm situation during heightened patient activity. For example, respiration measurements by methods such as bio-impedance and pulse oximetry can be seriously compromised by patient gross motion. Persons of ordinary skill in the art would appreciate that ECG signal can be compromised by motion. To assess motion induced artifacts, an analysis of motion signal from the accelerometer is used to correlate specific noise in the ECG signal with specific patient motion activity, including walking. Such sufficiently positive correlation enables false ECG alarms to be suppressed. In another embodiment use of accelerometer signals in conjunction with other physiological parameters enables improvement in the level of confidence for an alarm situation. For example, a possible marginal arrhythmia detected on the ECG which accompanied by a motion signal consistent with fainting is promoted to a higher alarm priority.


In another embodiment, changes in patient posture detected using the accelerometer is used to analyze and interpret measured changes in ECG ST Segment. It is well-known to those of ordinary skill in the art that the ST Segment is a portion of the ECG waveform which is monitored to identify ongoing myocardial infarction. Sometimes the ST Segment levels change with patient position as a result of the movement of the heart inside the chest relative to the ECG electrodes. ST segment changes due to position change are, however, not significant. Accelerometer signals provide necessary information conveying that positional changes preceded ST segment changes thereby enabling demotion of the alarm significance of an ST segment change.


According to one aspect of the present invention, motion signals from the accelerometer are used to modify overall sensitivity of the patient alarm system. In one embodiment, if the accelerometer signal analysis strongly suggests that the patient is walking or is very active the sensitivity of alarm system in the monitor is appropriately reduced. The objective here is to reduce false alarms that are induced by patient activity. According to another aspect of the present invention, patient activity level, monitored with accelerometer signals, is used to vary the need and kind of analysis that is performed on other physiological parameters. For example if the patient activity level is high due to activities such as walking or using a treadmill, then an ECG analysis for the patient is suspended during the period of the activity as ECG analysis requires high signal quality. Instead, in one embodiment, the overall sensitivity levels of the alarm system is pared down so that motion induced noise signals do not trigger false alarms while the some basic parameter analysis is continued.


According to a yet another aspect of the present invention, heart valve sounds are measured (such as by placing a microphone on the chest) to monitor mechanical activity of the heart to improve overall patient monitoring and also to reduce false alarms.


In one embodiment, heart valve sounds are used as a measure of patient pulse activity. The valve sounds from the heart form an independent pulse signal which is used to differentiate noise from signal at the ECG electrodes. As a first step, valve sound signature which matches each QRS location detected on an ECG is identified and recorded. In the next step, the quality of the recorded valve sound signals is determined based on parameters such as the strength, consistency, quality and regularity of the sound signal on a beat to beat basis. The determined sound quality measurement or signal to noise ratio is estimated on a continuous basis. The resultant valve sound quality is thereafter used to weigh how strongly the data from the sound channel (such as a microphone placed on the patient's chest) is used to promote or suppress alarm data from other physiological parameter measuring channels/sources such as ECG electrodes.


In another embodiment valve sounds from the heart form an independent pulse signal which are used to identify non-perfusing beats and pulseless electrical activity. It should be understood by persons of ordinary skill in the art that pulseless electrical activity is a general case of electromechanical disassociation in the heart. In some arrhythmia cases it is advantageous to identify beats for which there is no mechanical response. In other words, these beats are non-perfusing in that they have an electrical signal (probably abnormal) but do not cause the heart to pump. For example, there are cases in which pacemakers induce electrical signals in the heart which are detected by the ECG parameter, but which do not produce effective mechanical pumping. In this case, mechanical response, by way of valve sound signals measured on a beat by beat basis, in conjunction with ECG signals, enable identification of such events and alarm appropriately. For example, if an arrhythmia event detected at the ECG is verified by the valve sound signal there is an increased probability that this is a real event and would enable promoting this alarm due to the increased confidence in the correctness of the alarm. Such a scenario exists, for example, if the ECG analysis suggests a pause or asystole (no beats detected) and the heart valve sound signal also suggests no mechanical motion. This is a case of confirmed pause or asystole diagnosis and this alarm is promoted with confidence. Similarly, if an event is detected by the ECG but is not indicated by the heart valve sound signal, then the event alarm is suppressed or demoted. For example, the ECG signal may indicate a run of irregular beats that suggests a ventricular tachycardia. However, a high quality heart valve sound signal suggests that the pulse rate does not match the irregular beats that the ECG analysis is detecting. Therefore, in this case the alarm for the irregular beats is suppressed or demoted.

Claims
  • 1. A non-transitory computer readable medium configured to store a plurality of programmatic instructions that, when executed, process data indicative of physiological parameters, said non-transitory computer readable medium comprising: code for receiving accelerometer data generated by an accelerometer device, wherein said accelerometer data comprises a plurality of features, wherein each of the plurality of features has a time of occurrence associated therewith, wherein said accelerometer data is indicative of a position of a wearer of the accelerometer device, wherein the code for receiving the accelerometer data is adapted to receive data indicative of movement in three axes, and wherein the accelerometer data comprises three waveforms corresponding to the movement in three axes;code for monitoring the accelerometer data for changes in the position of the wearer for at least some of the times of occurrence; andcode for causing an alarm, indicative of a fall of the wearer, to issue, wherein the alarm is issued if the monitoring is indicative of a change from a first position to a second position and wherein the second position is a supine position.
  • 2. The non-transitory computer readable medium of claim 1 wherein the code for receiving the accelerometer data comprises receiving relative mean values of each of the three waveforms to indicate the position of the wearer.
  • 3. The non-transitory computer readable medium of claim 2, wherein the position of the wearer is at least one of upright, supine, or partially propped up.
  • 4. The non-transitory computer readable medium of claim 1 further comprising code for correlating changes in each of the three waveforms.
  • 5. The non-transitory computer readable medium of claim 1 wherein the code for receiving the accelerometer data is indicative of a measurement of force applied on the accelerometer device in each of three different orthogonal directions.
  • 6. The non-transitory computer readable medium of claim 1, wherein the code for monitoring the accelerometer data for changes in the position of the wearer for at least some of the times of occurrence comprises monitoring the accelerometer data for changes in spatial orientation of the accelerometer device relative to a gravitational field of Earth.
  • 7. The non-transitory computer readable medium of claim 1, wherein the change from the first position to the second position is indicated by a change in a mean level of each of the three waveforms.
  • 8. The non-transitory computer readable medium of claim 1, wherein the code for monitoring the accelerometer data for changes in the position of the wearer for at least some of the times of occurrence comprises code for monitoring an activity level of the wearer.
  • 9. The non-transitory computer readable medium of claim 8, wherein the code for monitoring an activity level of the wearer comprises code for monitoring sleep positions of the wearer.
  • 10. The non-transitory computer readable medium of claim 9, wherein the code for monitoring sleep positions of the wearer comprises code for measuring a number of sleep position changes per hour.
  • 11. The non-transitory computer readable medium of claim 10, wherein the code for measuring number of sleep position changes per hour comprises raising an alarm if the measured number of sleep positions per hour is less than a predefined number.
  • 12. A non-transitory computer readable medium adapted to store a plurality of programmatic instructions that, when executed, cause data indicative of physiological parameters to be processed, said non-transitory computer readable medium comprising: code that, when executed, is adapted to receive accelerometer data generated by an accelerometer device, wherein the code adapted to receive the accelerometer data is configured to receive data indicative of movement in three orthogonal axes, wherein said data has a time of occurrence associated therewith, wherein the code adapted to receive the accelerometer data is configured to record said data along the three orthogonal axes, wherein said accelerometer data is indicative of a position of a wearer of the accelerometer device, and wherein the accelerometer data comprises three waveforms corresponding to the three orthogonal axes;code that, when executed, is adapted to monitor the accelerometer data for changes in the position of the wearer for at least some of the times of occurrence; andcode that, when executed, is adapted to cause an alarm to issue, if the monitoring is indicative of a change from a first position of the wearer to a second position of the wearer, wherein the second position is a supine position.
  • 13. The non-transitory computer readable medium of claim 12, wherein the change from the first position to the second position is indicative of a fall of the wearer.
  • 14. The non-transitory computer readable medium of claim 12, wherein said accelerometer data comprises a plurality of features, wherein each of the plurality of features has said time of occurrence associated therewith.
  • 15. The non-transitory computer readable medium of claim 14 wherein the code that, when executed, is adapted to monitor the accelerometer data comprises code configured to monitor an activity level of the wearer.
  • 16. The non-transitory computer readable medium of claim 15 wherein the code that, when executed, is adapted to monitor the activity level of the wearer comprises code adapted to monitor sleep positions of the wearer.
  • 17. The non-transitory computer readable medium of claim 16, wherein the code for monitoring sleep positions of the wearer comprises code adapted to measure a number of sleep position changes per hour of the wearer.
  • 18. The non-transitory computer readable medium of claim 16, wherein the code adapted to measure the number of sleep position changes per hour comprises causing an alarm to issue if the measured number of sleep positions per hour is less than a predefined number.
  • 19. The non-transitory computer readable medium of claim 15, wherein the code that, when executed, monitors the activity level of the wearer comprises code for correlating specific noise in an ECG signal of the wearer with a motion activity of the wearer and for promoting the alarm to a higher priority level based on the correlation.
  • 20. The non-transitory computer readable medium of claim 12 wherein the change from the first position to the second position is indicated by a change in a mean level of each of the three orthogonal waveforms.
CROSS-REFERENCE

The present application is a division application of U.S. patent application Ser. No. 15/463,250, entitled “Methods & Systems to Determine Multi-Parameter Managed Alarm Hierarchy During Patient Monitoring” and filed on Mar. 20, 2017, which is a continuation application of U.S. patent application Ser. No. 13/045,539, of the same title, filed on Mar. 11, 2011, and issued as U.S. Pat. No. 9,629,566 on Apr. 25, 2017, both of which are incorporated herein by reference in their entirety.

US Referenced Citations (556)
Number Name Date Kind
2003120 William May 1935 A
2004116 George Jun 1935 A
2005005 Preston Jun 1935 A
2005146 Kotrbaty Jun 1935 A
2006213 Halliday Jun 1935 A
2007120 Holmes Jul 1935 A
2008221 Molander Jul 1935 A
2008251 Hillebrand Jul 1935 A
2009121 Price Jul 1935 A
2009326 Sanchez-Vello Jul 1935 A
2246464 Gerber Jun 1941 A
2808580 Fuller Oct 1957 A
2820651 Phillips Jan 1958 A
2912858 Fuller Nov 1959 A
2944547 Ziherl Jul 1960 A
3517639 Whitsel Jun 1970 A
3608545 Novack Sep 1971 A
3618592 Stewart Nov 1971 A
3673863 Spacek Jul 1972 A
3689908 Ray Sep 1972 A
3733482 Miller May 1973 A
3757577 Bozek Sep 1973 A
3844171 Rodger Oct 1974 A
3897606 Schleining Aug 1975 A
3938551 Henkin Feb 1976 A
3954010 Hilblom May 1976 A
3981329 Wohlwend Sep 1976 A
4064826 Pauli Dec 1977 A
4148312 Bird Apr 1979 A
4167115 Stoever Sep 1979 A
4323064 Hoenig Apr 1982 A
4428230 Testone Jan 1984 A
4428507 Sneider Jan 1984 A
4513294 Anderson Apr 1985 A
4557216 Demyon Dec 1985 A
4615547 Sutcliffe Oct 1986 A
4625731 Quedens Dec 1986 A
4630485 Wastlsr Dec 1986 A
4630486 Miles Dec 1986 A
4643693 Rubinstein Feb 1987 A
4697450 Bachman Oct 1987 A
4869253 Craig Sep 1989 A
4879997 Bickford Nov 1989 A
4899585 Kulha Feb 1990 A
4903222 Carter Feb 1990 A
4944305 Takatsu Jul 1990 A
4989791 Ridenour Feb 1991 A
4991576 Henkin Feb 1991 A
4993683 Kreuzer Feb 1991 A
5086397 Schuster Feb 1992 A
5087906 Eaton Feb 1992 A
5101851 Abadi Apr 1992 A
5144898 Posly Sep 1992 A
5174163 Gussman Dec 1992 A
5197480 Gebhardt Mar 1993 A
5213108 Bredesen May 1993 A
5222486 Vaughn Jun 1993 A
5231981 Schreiber Aug 1993 A
5233975 Choate Aug 1993 A
5253641 Choate Oct 1993 A
5262944 Weisner Nov 1993 A
5291182 Wiseman Mar 1994 A
5292564 Lee Mar 1994 A
5311908 Barone May 1994 A
5319363 Welch Jun 1994 A
5322069 Gallant Jun 1994 A
5331549 Crawfordjr Jul 1994 A
5333106 Lanpher Jul 1994 A
5339826 Schmidt Aug 1994 A
5348008 Bornn Sep 1994 A
5372389 Tam Dec 1994 A
5373746 Bloss Dec 1994 A
5375604 Kelly Dec 1994 A
5377399 Ogawa Jan 1995 A
5419332 Sabbah May 1995 A
5438983 Falcone Aug 1995 A
5467954 Wekell Nov 1995 A
5473536 Wimmer Dec 1995 A
5482050 Smokoff Jan 1996 A
5497766 Foster Mar 1996 A
5502853 Singleton Apr 1996 A
5515083 Casebolt May 1996 A
5520191 Karlsson May 1996 A
5537992 Bjoernstijerna Jul 1996 A
5553296 Forrest Sep 1996 A
5558418 Lambright Sep 1996 A
5563495 Tomiyori Oct 1996 A
5584291 Vapola Dec 1996 A
5586909 Saba Dec 1996 A
5603330 Suga Feb 1997 A
5633457 Kilar May 1997 A
5682526 Smokoff Oct 1997 A
5684504 Verhulst Nov 1997 A
5687717 Halpern Nov 1997 A
5692494 Pernetti Dec 1997 A
5715813 Guevrekian Feb 1998 A
5718235 Golosarsky Feb 1998 A
5724025 Tavori Mar 1998 A
5724985 Snell Mar 1998 A
5749367 Gamlyn May 1998 A
5752917 Fuchs May 1998 A
5765842 Phaneuf Jun 1998 A
5779305 Hocking Jul 1998 A
5787298 Broedner Jul 1998 A
5800360 Kisner Sep 1998 A
5800387 Duffy Sep 1998 A
5819741 Karlsson Oct 1998 A
5852440 Grossman Dec 1998 A
5855550 Lai Jan 1999 A
5868133 Devries Feb 1999 A
5904328 Leveridge May 1999 A
5947907 Duich Sep 1999 A
5956013 Raj Sep 1999 A
5966760 Gallant Oct 1999 A
5975081 Hood Nov 1999 A
6005767 Ku Dec 1999 A
6008809 Brooks Dec 1999 A
6024089 Wallace Feb 2000 A
6042548 Giuffre Mar 2000 A
6048044 Biggel Apr 2000 A
6050940 Braun Apr 2000 A
6063028 Luciano May 2000 A
6096025 Borders Aug 2000 A
6099093 Spence Aug 2000 A
6115643 Stine Sep 2000 A
6131571 Lampotang Oct 2000 A
6134537 Pao Oct 2000 A
6146523 Kenley Nov 2000 A
6155255 Lambert Dec 2000 A
6167401 Csipkes Dec 2000 A
6188407 Smith Feb 2001 B1
6221012 Maschke Apr 2001 B1
6269813 Fitzgerald Aug 2001 B1
6322502 Schoenberg Nov 2001 B1
6338823 Furukawa Jan 2002 B1
6339732 Phoon Jan 2002 B1
6347310 Passera Feb 2002 B1
6349436 Kreuzer Feb 2002 B1
6364834 Reuss Apr 2002 B1
6383136 Jordan May 2002 B1
6396583 Clare May 2002 B1
6406426 Reuss Jun 2002 B1
6416471 Kumar Jul 2002 B1
6424860 Karlsson Jul 2002 B1
6435690 Till Aug 2002 B1
6443889 Groth Sep 2002 B1
D467001 Buczek Dec 2002 S
6488029 Hood Dec 2002 B1
6536430 Smith Mar 2003 B1
6541758 Yashiro Apr 2003 B2
6554238 Hibberd Apr 2003 B1
6571227 Agrafiotis May 2003 B1
6571792 Hendrickson Jun 2003 B1
6591694 Tsai Jul 2003 B2
6600662 Emmert Jul 2003 B1
6647341 Golub Nov 2003 B1
6650779 Vachtesvanos Nov 2003 B2
6674837 Taskar Jan 2004 B1
6692258 Kurzweil Feb 2004 B1
6692436 Bluth Feb 2004 B1
6699187 Webb Mar 2004 B2
6702754 Ogura Mar 2004 B2
6715722 Roberts Apr 2004 B2
6722010 Maruyama Apr 2004 B2
6725184 Gadh Apr 2004 B1
6735648 Onishi May 2004 B2
6771172 Robinson Aug 2004 B1
6790178 Mault Sep 2004 B1
6796264 Appenzeller Sep 2004 B1
6804656 Rosenfeld Oct 2004 B1
6824539 Novak Nov 2004 B2
6829501 Nielsen Dec 2004 B2
6868495 Glover Mar 2005 B1
6896241 Chen May 2005 B2
6931795 Baloga Aug 2005 B1
6933931 Lubarskyjr Aug 2005 B2
6944561 Tseng Sep 2005 B2
6985762 Brashears Jan 2006 B2
7006865 Cohen Feb 2006 B1
7013833 Lemberger Mar 2006 B2
7024569 Wright Apr 2006 B1
7031857 Tarassenko Apr 2006 B2
7038588 Boone May 2006 B2
7040175 Huang May 2006 B1
7055232 Maruyama Jun 2006 B2
7076435 McKeag Jul 2006 B1
7081091 Merrett Jul 2006 B2
RE39233 McGrath Aug 2006 E
7096864 Mayer Aug 2006 B1
7111852 Woods Sep 2006 B2
7117438 Wallace Oct 2006 B2
7128709 Saruya Oct 2006 B2
7137951 Pilarski Nov 2006 B2
7193233 Smith Mar 2007 B2
7216802 De La Huerga May 2007 B1
7219559 Sugi May 2007 B2
7223007 Fredley May 2007 B1
7234944 Nordin Jun 2007 B2
7256708 Rosenfeld Aug 2007 B2
7265676 Gordon Sep 2007 B2
7267666 Duchon Sep 2007 B1
7282029 Poulsen Oct 2007 B1
7310544 Brister Dec 2007 B2
7315825 Rosenfeld Jan 2008 B2
7319386 Collins, Jr. Jan 2008 B2
7336980 Kaikuranta Feb 2008 B1
7360454 Kawashima Apr 2008 B2
7371214 Kouchi May 2008 B2
7386340 Schlegel Jun 2008 B2
7390299 Weiner Jun 2008 B2
7439856 Weiner Oct 2008 B2
7468032 Stahmann Dec 2008 B2
7469601 Sugi Dec 2008 B2
7489250 Bock Feb 2009 B2
D589959 Han Apr 2009 S
7516924 White Apr 2009 B2
7523040 Kirchhoff Apr 2009 B2
7529083 Jeong May 2009 B2
7530949 Alali May 2009 B2
7540187 Dillon Jun 2009 B1
7556039 Peirry Jul 2009 B1
7566307 Inukai Jul 2009 B2
7621500 Ishizaki Nov 2009 B2
7704212 Wekell Apr 2010 B2
7710567 Mentzer May 2010 B1
7751878 Merkle Jul 2010 B1
7756722 Levine Jul 2010 B2
7831670 Goodman Nov 2010 B2
7836882 Rumph Nov 2010 B1
7945452 Fathallah May 2011 B2
7974924 Holla Jul 2011 B2
8002701 John Aug 2011 B2
8027846 Schoenberg Sep 2011 B2
8033686 Recker Oct 2011 B2
8091422 Felske Jan 2012 B2
8147419 Krauss Apr 2012 B2
8190900 Corndorf May 2012 B2
8233272 Fidacaro Jul 2012 B2
8273018 Fackler Sep 2012 B1
8344847 Moberg Jan 2013 B2
8398408 Hansen Mar 2013 B1
8413271 Blanchard Apr 2013 B2
8544406 Fujihira Oct 2013 B2
8593275 Davis Nov 2013 B2
8704666 Bakerjr Apr 2014 B2
8798527 Gaines Aug 2014 B2
8811888 Wiesner Aug 2014 B2
8818260 Gaines Aug 2014 B2
8855550 Gaines Oct 2014 B2
8868028 Kaltsukis Oct 2014 B1
8897198 Gaines Nov 2014 B2
8903308 Wiesner Dec 2014 B2
8922330 Moberg Dec 2014 B2
8931702 Wekell Jan 2015 B2
8940147 Bartsch Jan 2015 B1
8943168 Wiesner Jan 2015 B2
9020419 Gaines Apr 2015 B2
9086313 Tobia Jul 2015 B2
9844637 Beduhn Dec 2017 B2
20010001179 Healy May 2001 A1
20010004234 Petelenz Jun 2001 A1
20010018332 Lustila Aug 2001 A1
20010027791 Wallace Oct 2001 A1
20010034475 Flach Oct 2001 A1
20020013517 West Jan 2002 A1
20020026941 Biondi Mar 2002 A1
20020032386 Sackner Mar 2002 A1
20020040954 Roberts Apr 2002 A1
20020060247 Krishnaswamy May 2002 A1
20020095424 Chung Jul 2002 A1
20020108011 Tanha Aug 2002 A1
20020138017 Bui Sep 2002 A1
20020161291 Kianl Oct 2002 A1
20020173991 Avitall Nov 2002 A1
20020193679 Malave Dec 2002 A1
20020196141 Boone Dec 2002 A1
20020196234 Gray Dec 2002 A1
20030028118 Dupree Feb 2003 A1
20030029451 Blair Feb 2003 A1
20030037786 Biondi Feb 2003 A1
20030065536 Hansen Apr 2003 A1
20030076015 Ehrenreich Apr 2003 A1
20030092974 Santoso May 2003 A1
20030114836 Estes Jun 2003 A1
20030117296 Seely Jun 2003 A1
20030120164 Nielsen Jun 2003 A1
20030130590 Bui Jul 2003 A1
20030135087 Hickle Jul 2003 A1
20030144699 Freeman Jul 2003 A1
20030145854 Hickle Aug 2003 A1
20030171898 Tarassenko Sep 2003 A1
20030191373 Blike Oct 2003 A1
20030197614 Smith Oct 2003 A1
20030209246 Schroeder Nov 2003 A1
20030210780 Pratt Nov 2003 A1
20030216621 Alpert Nov 2003 A1
20030231460 Moscovitch Dec 2003 A1
20030233129 Matos Dec 2003 A1
20040008825 Seeley Jan 2004 A1
20040011938 Oddsen Jan 2004 A1
20040015079 Berger Jan 2004 A1
20040021705 Baker Feb 2004 A1
20040024303 Banks Feb 2004 A1
20040032426 Rutledge Feb 2004 A1
20040054261 Kamataki Mar 2004 A1
20040054295 Ramseth Mar 2004 A1
20040073128 Hatlestad Apr 2004 A1
20040102687 Brashears May 2004 A1
20040103001 Mazar May 2004 A1
20040113895 Lubarsky Jun 2004 A1
20040116813 Selzer Jun 2004 A1
20040117209 Brown Jun 2004 A1
20040117233 Rapp Jun 2004 A1
20040118404 Wallace Jun 2004 A1
20040147818 Levy Jul 2004 A1
20040149892 Akitt Aug 2004 A1
20040153257 Munk Aug 2004 A1
20040158132 Zaleski Aug 2004 A1
20040172078 Chinchoy Sep 2004 A1
20040172222 Simpson Sep 2004 A1
20040186357 Soderberg Sep 2004 A1
20040220629 Kamath Nov 2004 A1
20040221077 Yen Nov 2004 A1
20040236192 Necolashehada Nov 2004 A1
20040240167 Ledbetter Dec 2004 A1
20040249298 Selevan Dec 2004 A1
20040249673 Smith Dec 2004 A1
20050005932 Berman Jan 2005 A1
20050010165 Hickle Jan 2005 A1
20050033124 Kelly Feb 2005 A1
20050033188 Whitaker Feb 2005 A1
20050038332 Saidara Feb 2005 A1
20050038821 Wallen Feb 2005 A1
20050054920 Washburn Mar 2005 A1
20050059924 Katz Mar 2005 A1
20050065417 Ali Mar 2005 A1
20050113650 Ione May 2005 A1
20050113704 Lawson May 2005 A1
20050124866 Elaz Jun 2005 A1
20050139213 Blike Jun 2005 A1
20050146431 Hastings Jul 2005 A1
20050148890 Hastings Jul 2005 A1
20050151640 Hastings Jul 2005 A1
20050177096 Bollish Aug 2005 A1
20050192845 Brinsfield Sep 2005 A1
20050193263 Watt Sep 2005 A1
20050229110 Gegner Oct 2005 A1
20050251232 Hartley Nov 2005 A1
20060004475 Brackett Jan 2006 A1
20060013462 Sadikali Jan 2006 A1
20060022096 Chan Feb 2006 A1
20060042635 Niklewski Mar 2006 A1
20060053034 Hlathein Mar 2006 A1
20060058591 Garboski Mar 2006 A1
20060094970 Drew May 2006 A1
20060142808 Pearce Jun 2006 A1
20060155206 Lynn Jul 2006 A1
20060155589 Lane Jul 2006 A1
20060161295 Yun Jul 2006 A1
20060199618 Steer Sep 2006 A1
20060213517 Mashak Sep 2006 A1
20060226992 Al-Ali Oct 2006 A1
20060252999 Devaul Nov 2006 A1
20060258926 Ali Nov 2006 A1
20060261781 Oberding Nov 2006 A1
20060272141 Rudduck Dec 2006 A1
20060278270 Jones Dec 2006 A1
20060280621 Kinugawa Dec 2006 A1
20060282021 DeVaul Dec 2006 A1
20060282302 Hussain Dec 2006 A1
20060290525 Andersen Dec 2006 A1
20070007418 Lubbers Jan 2007 A1
20070028921 Banner Feb 2007 A1
20070032749 Overall Feb 2007 A1
20070044578 Jones Mar 2007 A1
20070047797 Vilella Mar 2007 A1
20070049127 Nordin Mar 2007 A1
20070050715 Behar Mar 2007 A1
20070051861 Teramachi Mar 2007 A1
20070060869 Tolle Mar 2007 A1
20070063850 Devaul Mar 2007 A1
20070093784 Leonard Apr 2007 A1
20070100213 Dossas May 2007 A1
20070107728 Ricciardelli May 2007 A1
20070108291 Bhatia May 2007 A1
20070120763 Depaepe May 2007 A1
20070136023 Schoenborn Jun 2007 A1
20070176931 Tivig Aug 2007 A1
20070180140 Welch Aug 2007 A1
20070197881 Wolf Aug 2007 A1
20070199388 Furkert Aug 2007 A1
20070199566 Be Aug 2007 A1
20070255116 Mehta Nov 2007 A1
20070265533 Tran Nov 2007 A1
20070276277 Booth Nov 2007 A1
20070296571 Kolen Dec 2007 A1
20080033254 Kamath Feb 2008 A1
20080039701 Ali Feb 2008 A1
20080039735 Hickerson Feb 2008 A1
20080051667 Goldreich Feb 2008 A1
20080077435 Muradia Mar 2008 A1
20080103375 Kiani May 2008 A1
20080117029 Dohrmann May 2008 A1
20080154909 Dam Jun 2008 A1
20080167569 Ermes Jul 2008 A1
20080170287 Champion Jul 2008 A1
20080177160 Al Ali Jul 2008 A1
20080177397 Davlin Jul 2008 A1
20080181465 Sauerwein Jul 2008 A1
20080194918 Kulik Aug 2008 A1
20080208381 Soga Aug 2008 A1
20080221418 Al-Ali Sep 2008 A1
20080221495 Steffens Sep 2008 A1
20080228045 Gao Sep 2008 A1
20080228089 Cho Sep 2008 A1
20080249376 Zaleski Oct 2008 A1
20080251003 Boston Oct 2008 A1
20080267790 Gaudet Oct 2008 A1
20080271736 Leonard Nov 2008 A1
20080275309 Stivoric Nov 2008 A1
20080281168 Gibson Nov 2008 A1
20080281170 Eshelman Nov 2008 A1
20080287763 Hayter Nov 2008 A1
20080294057 Parlikar Nov 2008 A1
20080310600 Clawson Dec 2008 A1
20080319331 Zizzo Dec 2008 A1
20090005651 Ward Jan 2009 A1
20090005703 Fasciano Jan 2009 A1
20090015116 Arceta Jan 2009 A1
20090024008 Brunner Jan 2009 A1
20090043171 Rule Feb 2009 A1
20090054743 Stewart Feb 2009 A1
20090055735 Zaleski Feb 2009 A1
20090069642 Gao Mar 2009 A1
20090076345 Manicka Mar 2009 A1
20090076397 Libbus Mar 2009 A1
20090099480 Salgo Apr 2009 A1
20090117784 Wu May 2009 A1
20090121592 De Nando May 2009 A1
20090124239 Tsuei May 2009 A1
20090131805 OBrien May 2009 A1
20090133609 Nethken May 2009 A1
20090149901 Jayne Jun 2009 A1
20090151720 Inoue Jun 2009 A1
20090182204 Semler Jul 2009 A1
20090190713 Wai Jul 2009 A1
20090192541 Ortiz Jul 2009 A1
20090193315 Gower Jul 2009 A1
20090200902 Mckay Aug 2009 A1
20090206713 Vilkas Aug 2009 A1
20090209849 Rowe Aug 2009 A1
20090213034 Wu Aug 2009 A1
20090237264 Bobey Sep 2009 A1
20090248173 Sasko Oct 2009 A1
20090275805 Lane Nov 2009 A1
20090292227 Scholten Nov 2009 A1
20090326340 Wang Dec 2009 A1
20100004539 Chen Jan 2010 A1
20100007588 Zygmunt Jan 2010 A1
20100014229 Horie Jan 2010 A1
20100056875 Schoenberg Mar 2010 A1
20100056877 Fein Mar 2010 A1
20100070417 Flynn Mar 2010 A1
20100073915 Nittou Mar 2010 A1
20100094096 Petruzzelli Apr 2010 A1
20100110019 Ozias May 2010 A1
20100137729 Pierry Jun 2010 A1
20100156655 Bullemer Jun 2010 A1
20100164452 Ruan Jul 2010 A1
20100175695 Jamison Jul 2010 A1
20100179400 Brauker Jul 2010 A1
20100198027 Dixon Aug 2010 A1
20100233891 Broeksteeg Sep 2010 A1
20100238138 Goertz Sep 2010 A1
20100245091 Singh Sep 2010 A1
20100259881 Choi Oct 2010 A1
20100261979 Kiani Oct 2010 A1
20100273530 Jarvis Oct 2010 A1
20100282256 Loescher Nov 2010 A1
20100285771 Peabody Nov 2010 A1
20100294405 Longinotti-Buitoni Nov 2010 A1
20100298655 Mccombie Nov 2010 A1
20100298656 Mccombie Nov 2010 A1
20100298718 Gilham Nov 2010 A1
20100318578 Treu Dec 2010 A1
20100324380 Perkins Dec 2010 A1
20100324384 Moon Dec 2010 A1
20100324936 Vishnubhatla Dec 2010 A1
20110004071 Faiola Jan 2011 A1
20110006876 Moberg Jan 2011 A1
20110015493 Koschek Jan 2011 A1
20110054267 Fidacaro Mar 2011 A1
20110055205 Scott Mar 2011 A1
20110071420 Pierre Mar 2011 A1
20110077971 Surwit Mar 2011 A1
20110087756 Biondi Apr 2011 A1
20110088694 Tobia Apr 2011 A1
20110092838 Helfenbein Apr 2011 A1
20110125040 Crawford May 2011 A1
20110130798 Elghazzawi Jun 2011 A1
20110138323 Skidmore Jun 2011 A1
20110146676 Dallam Jun 2011 A1
20110152629 Eaton Jun 2011 A1
20110164074 Frank Jul 2011 A1
20110190643 Zhang Aug 2011 A1
20110224531 Steiner Sep 2011 A1
20110225771 Bartnick Sep 2011 A1
20110227739 Gilham Sep 2011 A1
20110245579 Bruggeman Oct 2011 A1
20110245688 Arora Oct 2011 A1
20110257489 Banet Oct 2011 A1
20110270058 Price Nov 2011 A1
20110279383 Wilson Nov 2011 A1
20110279958 Clark Nov 2011 A1
20110295426 Georgeson Dec 2011 A1
20110298718 Chang Dec 2011 A1
20110301435 Albert Dec 2011 A1
20120030610 Diperna Feb 2012 A1
20120041783 Mckee Feb 2012 A1
20120041786 Yu Feb 2012 A1
20120075060 Connor Mar 2012 A1
20120075327 Mackenzie Mar 2012 A1
20120083906 Weatherhead Apr 2012 A1
20120093311 Nierzwick Apr 2012 A1
20120095778 Gross Apr 2012 A1
20120101396 Solosko Apr 2012 A1
20120101411 Hausdorff Apr 2012 A1
20120105233 Bobey May 2012 A1
20120105774 Fletcher May 2012 A1
20120108991 Song May 2012 A1
20120116331 Locke May 2012 A1
20120127103 Qualey May 2012 A1
20120136231 Markel May 2012 A1
20120180789 Tobia Jul 2012 A1
20120184120 Basta Jul 2012 A1
20120186583 Drapes Jul 2012 A1
20120203491 Sun Aug 2012 A1
20120209984 Gonzalez-Banos Aug 2012 A1
20120232398 Roham Sep 2012 A1
20120233679 Shedrinsky Sep 2012 A1
20120245439 Andre Sep 2012 A1
20120265089 Orr Oct 2012 A1
20120330675 Muradia Dec 2012 A1
20130015966 Soomro Jan 2013 A1
20130030258 Cheung Jan 2013 A1
20130107445 Reber May 2013 A1
20130116514 Kroner May 2013 A1
20130162426 Wiesner Jun 2013 A1
20130267861 Vassallo Oct 2013 A1
20140142963 Hill May 2014 A1
20140153747 Contolini Jun 2014 A1
20140275873 Fries Sep 2014 A1
20140337777 Senesac Nov 2014 A1
20150018703 Shetty Jan 2015 A1
20160120445 Peluso May 2016 A1
20170215797 Cretu-Petra Aug 2017 A1
Foreign Referenced Citations (113)
Number Date Country
1293943 May 2001 CN
1293943 May 2001 CN
1348740 May 2002 CN
1518427 Aug 2004 CN
1593764 Mar 2005 CN
1688256 Oct 2005 CN
1781107 May 2006 CN
1839311 Sep 2006 CN
1943505 Apr 2007 CN
1983258 Jun 2007 CN
100391403 Jun 2008 CN
101194278 Jun 2008 CN
101496923 Aug 2009 CN
101496923 Aug 2009 CN
101501683 Aug 2009 CN
101521845 Sep 2009 CN
101521845 Sep 2009 CN
101547716 Sep 2009 CN
101611410 Dec 2009 CN
201570216 Sep 2010 CN
201594642 Sep 2010 CN
101893916 Nov 2010 CN
201708829 Jan 2011 CN
102184312 Sep 2011 CN
102567624 Jul 2012 CN
9415672 Nov 1994 DE
102006011151 Sep 2007 DE
0596509 May 1994 EP
0686900 Dec 1995 EP
0686900 Dec 1995 EP
0955007 Nov 1999 EP
1054338 Nov 2000 EP
1227752 May 2001 EP
1197178 Apr 2002 EP
1406198 Apr 2004 EP
1449558 Aug 2004 EP
1852060 Nov 2007 EP
1868123 Dec 2007 EP
1197178 Jul 2008 EP
2555668 Feb 2013 EP
2641151 Sep 2013 EP
2651482 Oct 2013 EP
2709518 Mar 2014 EP
2805564 Sep 2015 EP
191214095 Oct 1912 GB
568212 Mar 1945 GB
2348715 Oct 2000 GB
2389290 Dec 2003 GB
2438495 Nov 2007 GB
13286735 Dec 1991 JP
05143611 Jun 1993 JP
15184550 Jul 1993 JP
15341771 Dec 1993 JP
07163527 Jun 1995 JP
08504345 May 1996 JP
08504531 May 1996 JP
08275926 Oct 1996 JP
19108194 Apr 1997 JP
3059292 Jul 1999 JP
2001052281 Feb 2001 JP
2003210422 Jul 2003 JP
2004208855 Jul 2004 JP
2005529396 Sep 2005 JP
2008520026 Jun 2008 JP
2008532587 Aug 2008 JP
2009054381 Mar 2009 JP
2009211589 Sep 2009 JP
2009245435 Oct 2009 JP
2009544431 Dec 2009 JP
2010086535 Apr 2010 JP
2011078640 Apr 2011 JP
2012529926 Nov 2012 JP
9415523 Jul 1994 WO
1994015523 Jul 1994 WO
1999018705 Apr 1999 WO
1999027326 Jun 1999 WO
2000042911 Jul 2000 WO
0134023 May 2001 WO
03091841 Nov 2003 WO
03102850 Dec 2003 WO
2004038669 May 2004 WO
2004070994 Aug 2004 WO
2005101276 Oct 2005 WO
2005114524 Dec 2005 WO
2006051464 May 2006 WO
2006090371 Aug 2006 WO
2006094055 Sep 2006 WO
2008005921 Jan 2008 WO
2008079746 Jul 2008 WO
2010126797 Nov 2010 WO
2010126797 Nov 2010 WO
2010126916 Nov 2010 WO
2010126916 Nov 2010 WO
2010144720 Dec 2010 WO
2011001302 Jan 2011 WO
2011001302 Jan 2011 WO
2011046636 Apr 2011 WO
2011047363 Apr 2011 WO
2011119512 Sep 2011 WO
2012068564 May 2012 WO
2012068565 May 2012 WO
2012068567 May 2012 WO
2012068568 May 2012 WO
2012083276 Jun 2012 WO
2012083281 Jun 2012 WO
2012125135 Sep 2012 WO
2012128808 Sep 2012 WO
2012158720 Nov 2012 WO
2013056171 Apr 2013 WO
2013173520 Nov 2013 WO
2013173521 Nov 2013 WO
2014055660 Apr 2014 WO
2014194193 Dec 2014 WO
Non-Patent Literature Citations (46)
Entry
“BleaseSirius Anesthesia Systems User Manual 1073-0212-00/REV. B”, Dec. 1, 2010, pp. 1-258, XP055209666.
“Lifegard II Patient Monitor Operator's Manual”, Jan. 1, 2006, pp. 1-1, XP055209485.
Google patents search, Sep. 25, 2015, U.S. Appl. No. 14/044,524.
IntelliVue Patient Monitor; MP20/30, MP40/50, MP60/70/80/90, Release G.0 with Software Revision G.0x.xx (PHILIPS) Sep. 2008; pp. 4, 10, 19, 20, 46-49, 82, 326, 348, 420, 422, 424, 452; Accessed on Sep. 30, 2013: <http://www.mc.vanderbilt.edu/documents/nursingeducationresources/files/MP20-MP90%20Instructions%20for%20Use%20Manual%20Rev_G_0%20%20English%20M8000-9001K.pdf>.
International Preliminary Report on Patentability, PCT/US12/38000, dated Nov. 13, 2013.
International Preliminary Report on Patentability, PCT/US2006/007269, dated Sep. 11, 2007, Spacelabs Medical.
International Preliminary Report on Patentability, PCT/US2011/028007, dated Sep. 17, 2013, International Search Authority.
International Preliminary Report on Patentability, PCT/US2011/065678, dated Jun. 18, 2013, International Search Authority.
International Preliminary Report on Patentability, PCT/US2011/065685, dated Jun. 18, 2013.
International Preliminary Report on Patentability for PCT/US2011/061554, dated Feb. 25, 2014.
International Search Report, PCT/US2011/028007, dated Jul. 11, 2011, International Search Authority.
International Search Report, PCT/US2011/065685, dated May 8, 2012, International Search Authority.
International Search Report for PCT/US06/07269, dated Aug. 28, 2006.
International Search Report for PCT/US10/32635, dated Jul. 23, 2010.
International Search Report for PCT/US10/34025, dated Aug. 9, 2010.
International Search Report for PCT/US12/38000, dated Oct. 23, 2012.
International Search Report for PCT/US2010/052977, dated Mar. 18, 2011.
International Search Report for PCT/US2011/029278, dated Aug. 2, 2011.
International Search Report for PCT/US2011/061554, dated Feb. 14, 2014.
International Search Report for PCT/US2011/061555, dated Apr. 17, 2012.
International Search Report for PCT/US2011/061558, dated Aug. 10, 2012.
International Search Report for PCT/US2011/065676, dated Sep. 20, 2012.
International Search Report for PCT/US2011/065678, dated Jun. 29, 2012.
International Search Report for PCT/US2011/61557, dated Apr. 23, 2012.
International Search Report for PCT/US2012/060125, dated Apr. 19, 2013.
International Search Report for PCT/US2013/041246, dated Dec. 9, 2013.
International Search Report for PCT/US2013/041247, dated Jan. 10, 2014.
International Search Report for PCT/US2013/063087, dated Mar. 6, 2014.
International Search Report for PCT/US2014/040225, dated Nov. 5, 2014.
Schoenberg, Roy, MD; Sands, Daniel Z MD MPH; Safran, Charles, MD; Center for Clinical Computing, Beth Israel Deaconess Medical Center, Harvard Medical School, “Making ICU Alarms Meaningful: a comparison of traditional vs. trend-based algorithms” (AMIA '99 Annual Symposium), 1999, pp. 1-5.
Philips: ‘IntelliVue Patient Monitor; MP20/30, MP40/50, MP60/70/80/90’, Internet Citation, Sep. 1, 2008, pp. 2PP, I-X, 1, XP003034216.
Anonymous: ‘Docking station-wikipedia, the free encyclopedia’, Feb. 20, 2012, XP055284610.
Anonymous: ‘Pogo pin-wikipedia, the free encyclopedia’, Apr. 28, 2012, XP055284974.
Anonymous: “Routing table”, Wikipedia, Oct. 3, 2012 (Oct. 3, 2012), XP055321398, Retrieved from the Internet: URL: https://en.wikipedia.org/w/index.php?title=Routing_table&oldid=515747820, [retrieved on Nov. 21, 2016].
Anonymous: “Metrics (networking)”, Wikipedia, Jul. 18, 2012 (Jul. 18, 2012), XP055321558, Retrieved from the Internet: URL: https://en.wikipedia.org/w/index.php?title=Metrics_(networking)&oldid=502970743, [retrieved on Nov. 22, 2016].
GE Healthcare, Modular monitoring for critical care, iMM Solar 8000i and iMM Transport Pro Monitors, 2005.
GE Healthcare, CARESCAPE Monitor B850, Engineered to help provide better care, 2009.
Anonymous: “Framebuffer—Wikipedia, the free encyclopedia”, Mar. 14, 2010, XP055307861, Retrieved from the Internet: URL—https://en.wikipedia.org/w/index.php?title=Framebuffer&oldid=349748376 [retrieved on Oct. 5, 2016].
“IntelliVue Patient Monitor MP20/30, MP40/50, MP60/70/80/90 Release G.0 with Software Revision G.0X.XX” Sep. 2008; See particularly pp. 3-19.
Kevin James: “Status Checks”, PC Interfacing and Data Acquisition: Techniques for Measurement, Instrumentation and Control, Jul. 17, 2000, pp. 66-67, XP055461225, ISBN:978-0-7506-4624-6.
Aerotel Ltd v Telco Holdings Ltd Ord Rev 1 [2007] RPC 7 (Aerotel/Macrossam).
Symbian v Comptroller General of Patents [2008] EWCA Civ 1066.
AT&T Knowledge Ventures LP and Cvon Innovations Ltd v Comptroller General of patents [2009] EWHX 343 (Pat).
HTC Europe Co Ltd v Apple line [2013] EWCA Civ 451.
Lantana v Comptroller-General of Patents [2013] EWHC 2673 (Pat).
Written Opinion of the International Searching Authority for PCT/US11/28007, dated Jul. 11, 2011.
Related Publications (1)
Number Date Country
20200294660 A1 Sep 2020 US
Divisions (1)
Number Date Country
Parent 15463250 Mar 2017 US
Child 16879398 US
Continuations (1)
Number Date Country
Parent 13045539 Mar 2011 US
Child 15463250 US